- Home
- TYRA vs SNDL Comparison
TYRA vs SNDL Comparison
Compare TYRA & SNDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TYRA
- SNDL
- Stock Information
- Founded
- TYRA 2018
- SNDL 2006
- Country
- TYRA United States
- SNDL Canada
- Employees
- TYRA N/A
- SNDL N/A
- Industry
- TYRA Biotechnology: Pharmaceutical Preparations
- SNDL Pharmaceuticals and Biotechnology
- Sector
- TYRA Health Care
- SNDL Health Care
- Exchange
- TYRA Nasdaq
- SNDL Nasdaq
- Market Cap
- TYRA 681.7M
- SNDL 635.7M
- IPO Year
- TYRA 2021
- SNDL 2019
- Fundamental
- Price
- TYRA $15.30
- SNDL $2.48
- Analyst Decision
- TYRA Strong Buy
- SNDL Strong Buy
- Analyst Count
- TYRA 7
- SNDL 1
- Target Price
- TYRA $30.71
- SNDL $5.00
- AVG Volume (30 Days)
- TYRA 160.3K
- SNDL 4.4M
- Earning Date
- TYRA 11-06-2025
- SNDL 11-04-2025
- Dividend Yield
- TYRA N/A
- SNDL N/A
- EPS Growth
- TYRA N/A
- SNDL N/A
- EPS
- TYRA N/A
- SNDL N/A
- Revenue
- TYRA N/A
- SNDL $692,339,389.00
- Revenue This Year
- TYRA N/A
- SNDL $5.30
- Revenue Next Year
- TYRA N/A
- SNDL $4.11
- P/E Ratio
- TYRA N/A
- SNDL N/A
- Revenue Growth
- TYRA N/A
- SNDL 3.54
- 52 Week Low
- TYRA $6.42
- SNDL $1.15
- 52 Week High
- TYRA $29.60
- SNDL $2.89
- Technical
- Relative Strength Index (RSI)
- TYRA 69.86
- SNDL 49.73
- Support Level
- TYRA $13.29
- SNDL $2.37
- Resistance Level
- TYRA $13.98
- SNDL $2.89
- Average True Range (ATR)
- TYRA 0.68
- SNDL 0.16
- MACD
- TYRA 0.09
- SNDL -0.03
- Stochastic Oscillator
- TYRA 91.65
- SNDL 29.82
About TYRA Tyra Biosciences Inc.
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.
About SNDL SNDL Inc.
SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.